Assembly and localization of Toll-like receptor signalling complexes
暂无分享,去创建一个
Martyn F. Symmons | N. Gay | C. Bryant | M. Symmons | M. Gangloff | Monique Gangloff | Nicholas J. Gay | Clare E. Bryant
[1] N. Coussens,et al. Isolation of an endotoxin–MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[2] Giorgio Sirugo,et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis , 2007, Nature Genetics.
[3] N. Gay,et al. Structure and function of Toll receptors and their ligands. , 2007, Annual review of biochemistry.
[4] S. Paik,et al. Crystal Structure of the TLR1-TLR2 Heterodimer Induced by Binding of a Tri-Acylated Lipopeptide , 2007, Cell.
[5] S. Hatakeyama,et al. Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway. , 2010, Molecular immunology.
[6] Takashi Saito,et al. T-Cell Receptor Microclusters Critical for T-Cell Activation Are Formed Independently of Lipid Raft Clustering , 2010, Molecular and Cellular Biology.
[7] M. Shirakawa,et al. Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling , 2009, Proceedings of the National Academy of Sciences.
[8] Thomas Miethke,et al. Crystal Structures of the Toll/Interleukin-1 Receptor (TIR) Domains from the Brucella Protein TcpB and Host Adaptor TIRAP Reveal Mechanisms of Molecular Mimicry* , 2013, The Journal of Biological Chemistry.
[9] F. Martinon,et al. RIP1 is an essential mediator of Toll-like receptor 3–induced NF-κB activation , 2004, Nature Immunology.
[10] J. Lippincott-Schwartz,et al. Imaging Intracellular Fluorescent Proteins at Nanometer Resolution , 2006, Science.
[11] Hiroyuki Oshiumi,et al. Spatiotemporal Mobilization of Toll/IL-1 Receptor Domain-Containing Adaptor Molecule-1 in Response to dsRNA1 , 2007, The Journal of Immunology.
[12] Takuma Shibata,et al. Structural Reorganization of the Toll-Like Receptor 8 Dimer Induced by Agonistic Ligands , 2013, Science.
[13] K. Takatsu,et al. A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses , 2007, The Journal of experimental medicine.
[14] Yuqiong Liang,et al. Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3–mediated pathway , 2011, Proceedings of the National Academy of Sciences.
[15] A. Smahi,et al. TLR3 Deficiency in Patients with Herpes Simplex Encephalitis , 2007, Science.
[16] R. Jerala,et al. The Ectodomain of the Toll-like Receptor 4 Prevents Constitutive Receptor Activation* , 2011, The Journal of Biological Chemistry.
[17] Shizuo Akira,et al. Toll/IL-1 Receptor Domain-Containing Adaptor Inducing IFN-β (TRIF) Associates with TNF Receptor-Associated Factor 6 and TANK-Binding Kinase 1, and Activates Two Distinct Transcription Factors, NF-κB and IFN-Regulatory Factor-3, in the Toll-Like Receptor Signaling 1 , 2003, The Journal of Immunology.
[18] R. Schekman,et al. UNC93B1 mediates differential trafficking of endosomal TLRs , 2013, eLife.
[19] M. Gangloff. Different dimerisation mode for TLR4 upon endosomal acidification? , 2012, Trends in biochemical sciences.
[20] B. Gérard,et al. TLR9 Activation Induces Normal Neutrophil Responses in a Child with IRAK-4 Deficiency: Involvement of the Direct PI3K Pathway , 2007, The Journal of Immunology.
[21] Hayyoung Lee,et al. The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex , 2009, Nature.
[22] B. Monks,et al. Ligand-induced conformational changes allosterically activate Toll-like receptor 9 , 2007, Nature Immunology.
[23] F. Martinon,et al. MyD88, an Adapter Protein Involved in Interleukin-1 Signaling* , 1998, The Journal of Biological Chemistry.
[24] Sarah E. Ewald,et al. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor , 2008, Nature.
[25] D. Standley,et al. Structures and interface mapping of the TIR domain-containing adaptor molecules involved in interferon signaling , 2013, Proceedings of the National Academy of Sciences.
[26] S. Akira,et al. The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[27] B. Seed,et al. Endoplasmic reticulum chaperone gp96 is required for innate immunity but not cell viability , 2001, Nature Cell Biology.
[28] P. Rod Dunbar,et al. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens , 2010, The Journal of experimental medicine.
[29] I. Wilson,et al. Structural Basis of TLR5-Flagellin Recognition and Signaling , 2012, Science.
[30] P. Ricciardi-Castagnoli,et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.
[31] J. Miyoshi,et al. Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells , 2007, Proceedings of the National Academy of Sciences.
[32] G. Hartmann,et al. Toll-like receptors (TLRs) and innate immunity , 2008 .
[33] N. Gay,et al. Conserved Features in the Extracellular Domain of Human Toll-like Receptor 8 Are Essential for pH-dependent Signaling* , 2006, Journal of Biological Chemistry.
[34] S. Horvat,et al. The Role of Intermediary Domain of MyD88 in Cell Activation and Therapeutic Inhibition of TLRs , 2011, The Journal of Immunology.
[35] M. Horiuchi,et al. A Molecular Mechanism for Toll-IL-1 Receptor Domain-containing Adaptor Molecule-1-mediated IRF-3 Activation* , 2010, The Journal of Biological Chemistry.
[36] A. Bowie,et al. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling , 2007, Nature Reviews Immunology.
[37] S. Akira,et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution , 2002, Nature Immunology.
[38] B. Williams,et al. Rational design of immunostimulatory siRNAs. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[39] Michael C. Ostrowski,et al. Free Cholesterol Accumulation in Macrophage Membranes Activates Toll-Like Receptors and p38 Mitogen-Activated Protein Kinase and Induces Cathepsin K , 2009, Circulation research.
[40] S. Grinstein,et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9 , 2006, Nature Immunology.
[41] M. Sweet,et al. The TLR signalling adaptor TRIF/TICAM-1 has an N-terminal helical domain with structural similarity to IFIT proteins. , 2013, Acta crystallographica. Section D, Biological crystallography.
[42] R. Ebright,et al. Dynamically driven protein allostery , 2006, Nature Structural &Molecular Biology.
[43] M. Fessler,et al. Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol[S] , 2010, Journal of Lipid Research.
[44] S. Paik,et al. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. , 2009, Immunity.
[45] N. Harris,et al. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. , 2012, The New England journal of medicine.
[46] N. Gay,et al. Structure of toll-like receptors. , 2008, Handbook of experimental pharmacology.
[47] C. Brooks,et al. Characterizing the protonation state of cytosine in transient G·C Hoogsteen base pairs in duplex DNA. , 2013, Journal of the American Chemical Society.
[48] N. Gay,et al. Toll-like receptors as molecular switches , 2006, Nature Reviews Immunology.
[49] Sarah E. Ewald,et al. Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase , 2011, The Journal of experimental medicine.
[50] N. Gay,et al. Assembly of Oligomeric Death Domain Complexes during Toll Receptor Signaling* , 2008, Journal of Biological Chemistry.
[51] J. Casanova,et al. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. , 2010, Immunity.
[52] N. Gay,et al. Cytokine Spätzle binds to the Drosophila immunoreceptor Toll with a neurotrophin-like specificity and couples receptor activation , 2013, Proceedings of the National Academy of Sciences.
[53] R. Ulevitch,et al. MD-2 and TLR4 N-Linked Glycosylations Are Important for a Functional Lipopolysaccharide Receptor* , 2002, The Journal of Biological Chemistry.
[54] Hao Wu,et al. Helical assembly in the death domain (DD) superfamily. , 2012, Current opinion in structural biology.
[55] P. Nordlund,et al. The Crystal Structure of the Human Toll-like Receptor 10 Cytoplasmic Domain Reveals a Putative Signaling Dimer* , 2008, Journal of Biological Chemistry.
[56] I. Wilson,et al. Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[57] K. Burns,et al. Inhibition of Interleukin 1 Receptor/Toll-like Receptor Signaling through the Alternatively Spliced, Short Form of MyD88 Is Due to Its Failure to Recruit IRAK-4 , 2003, The Journal of experimental medicine.
[58] R. Flavell,et al. Toll-like receptor 3 promotes cross-priming to virus-infected cells , 2005, Nature.
[59] D. Davies,et al. Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA , 2008, Science.
[60] M. Fenton,et al. Cutting Edge: Differential Inhibition of TLR Signaling Pathways by Cell-Permeable Peptides Representing BB Loops of TLRs1 , 2007, The Journal of Immunology.
[61] J. Metzger,et al. Toll‐like receptor 9 binds single‐stranded CpG‐DNA in a sequence‐ and pH‐dependent manner , 2004, European journal of immunology.
[62] D. V. Von Hoff,et al. A Phase I Dose-Finding Study of the Novel Toll-like Receptor 8 Agonist VTX-2337 in Adult Subjects with Advanced Solid Tumors or Lymphoma , 2014, Clinical Cancer Research.
[63] Z. Zhou,et al. Lateral clustering of TLR3:dsRNA signaling units revealed by TLR3ecd:3Fabs quaternary structure. , 2012, Journal of molecular biology.
[64] C. Janeway. Approaching the asymptote? Evolution and revolution in immunology. , 1989, Cold Spring Harbor symposia on quantitative biology.
[65] L. Tong,et al. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains , 2000, Nature.
[66] H. Ploegh,et al. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9 , 2008, Nature Immunology.
[67] M. Shirakawa,et al. Functional assessment of the mutational effects of human IRAK4 and MyD88 genes. , 2014, Molecular immunology.
[68] Y. Lo,et al. Helical assembly in the MyD88:IRAK4:IRAK2 complex in TLR/IL-1R signaling , 2010, Nature.
[69] J. Qin,et al. IRAK‐M mediates Toll‐like receptor/IL‐1R‐induced NFκB activation and cytokine production , 2013, The EMBO journal.
[70] T. Mizutani,et al. A Protein Associated with Toll-Like Receptor 4 (PRAT4A) Regulates Cell Surface Expression of TLR41 , 2006, The Journal of Immunology.
[71] E. Beutler,et al. Synergy between TLR2 and TLR4: a safety mechanism. , 2001, Blood cells, molecules & diseases.
[72] M. Fessler,et al. Intracellular Lipid Flux and Membrane Microdomains as Organizing Principles in Inflammatory Cell Signaling , 2011, The Journal of Immunology.
[73] J. Inoue,et al. Cutting Edge: TNFR-Associated Factor (TRAF) 6 Is Essential for MyD88-Dependent Pathway but Not Toll/IL-1 Receptor Domain-Containing Adaptor-Inducing IFN-β (TRIF)-Dependent Pathway in TLR Signaling1 , 2004, Journal of Immunology.
[74] L. Pike,et al. Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking. , 2002, Biochemistry.
[75] D. Chaussabel,et al. Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. , 2011, The Journal of clinical investigation.
[76] Michael D. Mason,et al. Ultra-high resolution imaging by fluorescence photoactivation localization microscopy. , 2006, Biophysical journal.
[77] Yoshinori Nagai,et al. MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4 , 1999, The Journal of experimental medicine.
[78] S. Sprang,et al. Three-Dimensional Structure of a Complex between the Death Domains of Pelle and Tube , 1999, Cell.
[79] D. Davies,et al. The TLR3 signaling complex forms by cooperative receptor dimerization , 2008, Proceedings of the National Academy of Sciences.
[80] T. Nishiya,et al. Distinct roles of TIR and non‐TIR regions in the subcellular localization and signaling properties of MyD88 , 2007, FEBS letters.
[81] Inhibitors of TLR8 Reduce TNF Production from Human Rheumatoid Synovial Membrane Cultures1 , 2008, The Journal of Immunology.
[82] A. Bowie,et al. The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling. , 2010, Biochemical pharmacology.
[83] F. DiMaio,et al. Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection , 2011, Proceedings of the National Academy of Sciences.
[84] Hayyoung Lee,et al. Crystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist Eritoran , 2007, Cell.
[85] N. Gay,et al. Trif-related adapter molecule is phosphorylated by PKC{epsilon} during Toll-like receptor 4 signaling. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[86] N. Gay,et al. Trif-related adapter molecule is phosphorylated by PKC during Toll-like receptor 4 signaling , 2006 .
[87] Wei Zhang,et al. The crystal structure of the BAR domain from human Bin1/amphiphysin II and its implications for molecular recognition. , 2006, Biochemistry.
[88] E. Sundberg,et al. Recruitment of TLR adapter TRIF to TLR4 signaling complex is mediated by the second helical region of TRIF TIR domain , 2013, Proceedings of the National Academy of Sciences.
[89] E. Ikonen,et al. Functional rafts in cell membranes , 1997, Nature.
[90] E. Latz,et al. The Rab11a GTPase controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on phagosomes. , 2010, Immunity.
[91] J. Casanova,et al. Herpes Simplex Virus Encephalitis in Human UNC-93B Deficiency , 2006, Science.
[92] J. Banchereau,et al. Pyogenic Bacterial Infections in Humans with MyD88 Deficiency , 2003, Science.
[93] N. Gay,et al. The COP II adaptor protein TMED7 is required to initiate and mediate the delivery of TLR4 to the plasma membrane , 2014, Science Signaling.
[94] E. Latz,et al. Endocytic pathways regulate Toll‐like receptor 4 signaling and link innate and adaptive immunity , 2006, The EMBO journal.
[95] A. Iwasaki,et al. A Promiscuous Lipid-Binding Protein Diversifies the Subcellular Sites of Toll-like Receptor Signal Transduction , 2014, Cell.
[96] J. Liu,et al. Association of TIRAP (MAL) gene polymorhisms with susceptibility to tuberculosis in a Chinese population. , 2011, Genetics and molecular research : GMR.
[97] D. Shaw,et al. Conformational Coupling across the Plasma Membrane in Activation of the EGF Receptor , 2013, Cell.
[98] C. Robinson,et al. An Oligomeric Signaling Platform Formed by the Toll-like Receptor Signal Transducers MyD88 and IRAK-4* , 2009, The Journal of Biological Chemistry.
[99] J. Lakowicz,et al. Targeting TLR4 Signaling by TLR4 Toll/IL-1 Receptor Domain-Derived Decoy Peptides: Identification of the TLR4 Toll/IL-1 Receptor Domain Dimerization Interface , 2011, The Journal of Immunology.
[100] Y. Satow,et al. Crystal Structures of Human MD-2 and Its Complex with Antiendotoxic Lipid IVa , 2007, Science.
[101] Xuetao Cao,et al. Ras-related protein Rab10 facilitates TLR4 signaling by promoting replenishment of TLR4 onto the plasma membrane , 2010, Proceedings of the National Academy of Sciences.
[102] Joseph M. Connors,et al. Oncogenically active MYD88 mutations in human lymphoma , 2011, Nature.
[103] N. Gay,et al. What the Myddosome structure tells us about the initiation of innate immunity. , 2011, Trends in immunology.
[104] R. Medzhitov,et al. Phosphoinositide-Mediated Adaptor Recruitment Controls Toll-like Receptor Signaling , 2006, Cell.
[105] S. Akira,et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.
[106] N. Gay,et al. An Alanine-to-Proline Mutation in the BB-Loop of TLR3 Toll/IL-1R Domain Switches Signalling Adaptor Specificity from TRIF to MyD88 , 2013, The Journal of Immunology.
[107] N. Gay,et al. A Dimer of the Toll-Like Receptor 4 Cytoplasmic Domain Provides a Specific Scaffold for the Recruitment of Signalling Adaptor Proteins , 2007, PloS one.
[108] L. Golitz,et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. , 2004, Journal of the American Academy of Dermatology.
[109] N. Gay,et al. Two Human MYD88 Variants, S34Y and R98C, Interfere with MyD88-IRAK4-Myddosome Assembly , 2010, The Journal of Biological Chemistry.
[110] N. Tsuchimori,et al. TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules , 2011, Molecular Pharmacology.
[111] F. Granucci,et al. CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4 , 2011, Cell.
[112] Michael J Rust,et al. Sub-diffraction-limit imaging by stochastic optical reconstruction microscopy (STORM) , 2006, Nature Methods.